Sulfated Polysaccharides for Treating Rosacea
Author Information
Author(s): Zhang Jianxing, Xu Xiaoyu, Rao Narayanam V., Argyle Brian, McCoard Lindsi, Rusho William J., Kennedy Thomas P., Prestwich Glenn D., Krueger Gerald
Primary Institution: University of Utah
Hypothesis
A topically-applied SAGE could be used as a novel therapy for rosacea by binding and inhibiting the inflammatory activity of excess cationic cathelicidins.
Conclusion
SAGEs offer potential as novel mechanism-based therapies for rosacea and other skin diseases driven by LL-37 and RAGE interactions.
Supporting Evidence
- SAGEs were anti-inflammatory at ng/ml concentrations.
- SAGEs inhibited interleukin-8 production induced by LL-37.
- Topical application of SAGEs reduced erythema and PMN infiltration.
- SAGEs bound LL-37 and inhibited its biological activity.
Takeaway
This study found that a new type of sugar molecule can help reduce redness and inflammation in skin conditions like rosacea.
Methodology
The study tested semi-synthetic glycosaminoglycan ethers (SAGEs) on inflammation pathways in a mouse model of rosacea.
Participant Demographics
Primarily Caucasian women of Celtic descent.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website